Andrew D. Goldberg, Director of Tarsus Pharmaceuticals TARS, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/25.

AG

AG

Andrew D. Goldberg

Director

Company

Tarsus Pharmaceuticals TARS

First filing

23/06/26

Trades

22 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

06/25

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Tarsus PharmaceuticalsTARS	Open-market buy	23/12/15	23/12/19	1,000 sh	$18.96	$18,960	+50.0%